Recommended videos you might also like
00:35
Which is most the important method in reducing cardiovascular events: antihyp...
00:44
Wie hat sich die Evidenzbasis zur Unterstützung von RDN seit Veröffentlichung...
00:35
What team is necessary to set up an RDN service?
00:40
How is RDN best implemented into clinical practice?
00:26
Does RDN work without other antihypertensive medication?
00:34
Which evidence is most important to you to support the use of RDN in clinical...
What effect size should I expect from RDN, and what effect could that effect (reduction in blood pressure) have on cardiovascular morbidity and mortality?
HTN:RDN
426 videos
Sharing knowledge of renal denervation (RDN) as a new device-based therapy for control of raised blood pressure
Speakers
Prof. Dr. Weil is Director of the Cardiovascular center at the Sana Clinic in Lübeck. His clinical focus is...
Read More
Prof. Dr. Weil is Director of the Cardiovascular center at the Sana Clinic in Lübeck. His clinical focus is interventional therapy of coronary artery disease and arterial hypertension including renal denervation as well chronic heart failure
Show Less
Related Videos
Start a conversation